
è±ç²çã®ã¡ã«ããºã ãšæ²»çè¬ã®é²åãåå ããææ°æ²»çæ³ãŸã§
ç®æ¬¡
è±ç²çãšã¯äœããåºæ¬ç¥è
è±ç²çã®ã¡ã«ããºã ãå ç«ã·ã¹ãã ã®éå°åå¿ã®ä»çµã¿
è±ç²çæ²»çè¬ã®æŽå²çå€é·
ææ°ã®è±ç²çæ²»çæ³ãåå¥åå»çã®æä»£ãž
èªåã«åã£ãè±ç²ç察çã®éžã³æ¹
ããã®èšäºã¯ãããŸã§åèæ å ±ã§ããäœãå¿ã®äžèª¿ãæããããç¡çãããå»è ããã«çžè«ããŠãã ãããæ¬èšäºã¯2025幎3æ22æ¥æç¹ã®æ å ±ãå ã«æ§æããŠããŸãã
è±ç²çãšã¯äœããåºæ¬ç¥è
è±ç²çã¯ãç¹å®ã®æ€ç©ã®è±ç²ã«å¯Ÿããå ç«ã·ã¹ãã ã®éå°åå¿ã«ãã£ãŠåŒãèµ·ããããã¢ã¬ã«ã®ãŒæ§çŸæ£ã§ããæ¥æ¬ã§ã¯åœæ°ã®çŽ40%ãäœããã®è±ç²çãæã£ãŠãããšãããæ¥å ã®ã¹ã®ã»ãããè±ç²çãç¹ã«æåã§ããã幎éãéããŠæ§ã ãªæ€ç©ã®è±ç²ãçç¶ãåŒãèµ·ãããŸãã1
äž»ãªçç¶ïŒ
ãããã¿ã®é£ç¶çºäœ
æ°Žæ§æ§éŒ»æŒïŒãããããã錻氎ïŒ
錻éïŒéŒ»ã¥ãŸãïŒ
çŒã®ããã¿ãå è¡
åã®éåæãããã¿
è±ç²çã¯åãªããå£ç¯ã®äžèª¿ãã§ã¯ãªããQOLïŒç掻ã®è³ªïŒãèããäœäžãããå¯èœæ§ã®ããæ¬æ Œçãªå¥åº·åé¡ã§ãã2
è±ç²çã®ã¡ã«ããºã ãå ç«ã·ã¹ãã ã®éå°åå¿ã®ä»çµã¿
è±ç²çã¯ãæ¬æ¥ç¡å®³ãªè±ç²ã«å¯ŸããŠå ç«ã·ã¹ãã ãäžé©åã«åå¿ããããšã§çºçããŸãããã®è©³çްãªã¡ã«ããºã ãèŠãŠãããŸãããã3
1. æäœïŒãããïŒãã§ãŒãº
æäœãšã¯ãåããŠç¹å®ã®ã¢ã¬ã«ã²ã³ïŒã¢ã¬ã«ã®ãŒãåŒãèµ·ããç©è³ªïŒã«æ¥è§Šããéã«ãäœããããèŠã蟌ãéçšã§ãã
è±ç²ã錻ãç®ã®ç²èã«ä»çãããšãæš¹ç¶çްèãšåŒã°ããå ç«çްèããããææããŸã
æš¹ç¶çްèã¯è±ç²ã®äžéšïŒã¢ã¬ã«ã²ã³ïŒãTh2ãªã³ãçã«æç€ºããŸã
掻æ§åãããTh2ãªã³ãçã¯IL-4ãIL-13ãªã©ã®ãµã€ãã«ã€ã³ïŒå ç«çްèéã®æ å ±äŒéç©è³ªïŒãæŸåºããŸã
ãããã®ãµã€ãã«ã€ã³ã¯B现èãåºæ¿ããIgEæäœïŒå ç«ã°ãããªã³EïŒã®ç£çãä¿ããŸã
ç£çãããIgEæäœã¯å šèº«ã埪ç°ããè¥æºçްèã奜塩åºçã®è¡šé¢ã«çµåããŠåŸ æ©ããŸã4
ãã®æ®µéã§ã¯ããŸã ã¢ã¬ã«ã®ãŒçç¶ã¯çŸããŸãããäœããæ¬¡ã«è±ç²ãæ¥ããšãã®ããã®æºåããããŠããç¶æ ã§ãã
2. æåæäœåå¿ïŒå³æåã¢ã¬ã«ã®ãŒåå¿ïŒ
æäœåŸãåã³åãè±ç²ã«æ¥è§Šãããšãã¢ã¬ã«ã®ãŒåå¿ãåŒãèµ·ããããŸãã
è±ç²ã¢ã¬ã«ã²ã³ããè¥æºçްè衚é¢ã®IgEæäœãšçµåããŸã
ãã®çµåãåŒãéãšãªããè¥æºçްèã®è±é¡ç²ïŒã ã€ããã ãïŒãèµ·ãããŸã
è±é¡ç²ã«ããããã¹ã¿ãã³ããã€ã³ããªãšã³ãããã¹ã¿ã°ã©ã³ãžã³ãªã©ã®ååŠäŒéç©è³ªãæŸåºãããŸã5
3. ã¢ã¬ã«ã®ãŒçç¶ã®çºçã¡ã«ããºã
æŸåºãããååŠäŒéç©è³ªã¯ããããç¹æã®äœçšãæã¡ãè±ç²çã®çç¶ãåŒãèµ·ãããŸãã
ãã¹ã¿ãã³ãè¡ç®¡æ¡åŒµãè¡ç®¡ééæ§äº¢é²ãç¥èŠç¥çµã®åºæ¿ã«ããããã¿ãå¹³æ»çåçž®ã«ãããããã¿ãªã©ãåŒãèµ·ãããŸã
ãã€ã³ããªãšã³ãççåå¿ã®å¢åŒ·ãé·æéæç¶ãã錻éã®åå ãšãªããŸã
ããã¹ã¿ã°ã©ã³ãžã³ãè¡ç®¡æ¡åŒµãçŒçãççåå¿ãªã©ãåŒãèµ·ãããŸã6
ãããã®ååŠäŒéç©è³ªã®è€åçãªäœçšã«ããããããã¿ã錻氎ã錻ã¥ãŸããç®ã®ããã¿ãªã©ã®å žåçãªè±ç²ççç¶ãçŸããŸãã
4. é çºçžåå¿
ã¢ã¬ã«ã®ãŒåå¿ã«ã¯ã峿ååå¿ã®æ°æéåŸã«èµ·ãããé çºçžåå¿ããååšããŸããããã¯ã
æŸåºãããååŠäŒéç©è³ªã«ãããå¥œé žçã奜äžçãªã©ã®çç现èãç²èã«éãŸããŸã
ãããã®çްèãããã«ççãä¿é²ããç©è³ªãæŸåºããçç¶ãé·åŒãããŸã
ãã®æ ¢æ§çãªççããç¹ã«éŒ»ã¥ãŸããªã©ã®æç¶çãªçç¶ã®åå ãšãªããŸã7
è±ç²çæ²»çè¬ã®æŽå²çå€é·
è±ç²çæ²»çã¯æ°å幎ã®éã«å€§ããé²åããŠããŸãããäž»ãªæ²»çè¬ã®çºå±ãæç³»åã§èŠãŠãããŸãããã8
åæã®æ²»çæ³ïŒ1940幎代ã1960幎代ïŒ
第äžäžä»£æãã¹ã¿ãã³è¬
1940幎代ããéçºãå§ãŸã£ã第äžäžä»£æãã¹ã¿ãã³è¬ã¯ãè±ç²çæ²»çã®å é§ããšãªããŸããã
代衚çãªæåããžãã§ã³ããã©ãã³ãã¯ãã«ãã§ãã©ãã³
äœçšæ©åºããã¹ã¿ãã³å容äœïŒH1å容äœïŒããããã¯ãããã¹ã¿ãã³ã®äœçšãæå¶
ç¹åŸŽãè¡æ¶²è³é¢éãééããããã匷ãç æ°ã壿žãªã©ã®å¯äœçšãåé¡ã§ãã9
æ²»çã®å€æ§åïŒ1970幎代ã1990幎代ïŒ
ã¹ããã€ãè¬ã®æ®å
1970幎代ã«å ¥ãã屿ã¹ããã€ãè¬ãè±ç²çæ²»çã«çšããããããã«ãªããŸããã
代衚çãªæåããã¯ãã¡ã¿ãŸã³ããã«ãã«ãŸã³
äœçšæ©åºãççåå¿ãã®ãã®ãæå¶ããå€ãã®ååŠäŒéç©è³ªã®ç£çã»æŸåºãæãã
ç¹åŸŽãç¹éŒ»è¬ãç¹çŒè¬ãšããŠå±æäœ¿çšããããšã§ãå šèº«æ§ã®å¯äœçšãæžãããŸãã10
第äºäžä»£æãã¹ã¿ãã³è¬ã®ç»å Ž
1980幎代ã«ãªããšãç æ°ãªã©ã®äžæ¢ç¥çµç³»å¯äœçšãå€§å¹ ã«è»œæžãã第äºäžä»£æãã¹ã¿ãã³è¬ãéçºãããŸããã
代衚çãªæåããã«ãã§ããžã³ãã¢ã¹ãããŸãŒã«
ç¹åŸŽãè¡æ¶²è³é¢éãééãã«ãããç æ°ãå°ãªã
課é¡ãäžéšã®è¬å€ã§ã¯å¿èãžã®å¯äœçšïŒQTå»¶é·ïŒãå ±åãããŸãã11
çŸä»£ã®æ²»çè¬ïŒ2000幎代ãçŸåšïŒ
第äžäžä»£æãã¹ã¿ãã³è¬
ããå®å šæ§ãšå¹æãåäžããæ°äžä»£ã®æãã¹ã¿ãã³è¬ãéçºãããŸããã
代衚çãªæåãã¬ãã»ããªãžã³ããã¹ãã©ã¿ãžã³ããã§ããœãã§ããžã³
ç¹åŸŽã第äºäžä»£ã®æ¹è¯åã§ãé«ãéžææ§ãšå®å šæ§ãæã€12
ãã€ã³ããªãšã³åå®¹äœæ®æè¬
1990幎代åŸåãã2000幎代ã«ãããŠæ®åããæ°ããäœçšæ©åºã®è¬å€ã§ãã
代衚çãªæåãã¢ã³ãã«ã«ã¹ãããã©ã³ã«ã«ã¹ã
äœçšæ©åºããã€ã³ããªãšã³ã®äœçšããããã¯ããããšã§ãç¹ã«éŒ»éçç¶ã«å¹æãçºæ®
ç¹åŸŽãæãã¹ã¿ãã³è¬ãšã®äœµçšã§çžä¹å¹æãæåŸ ã§ãã13
ãµã€ãã«ã€ã³é»å®³è¬
ææ°ã®æ²»çè¬ãšããŠãã¢ã¬ã«ã®ãŒåå¿ã®æ ¹æ¬çãªã¡ã«ããºã ã«ä»å ¥ããè¬å€ãéçºãããŠããŸãã
代衚çãªæåããã¥ãã«ããïŒæIL-4/13åå®¹äœæäœïŒ
äœçšæ©åºãTh2ãªã³ãçãç£çãããµã€ãã«ã€ã³ïŒIL-4ãIL-13ïŒã®äœçšãé»å®³
ç¹åŸŽãéçäŸãæ¢åæ²»çã§å¹æäžååãªäŸã«çšããããçç©åŠç補å€14
ææ°ã®è±ç²çæ²»çæ³ãåå¥åå»çã®æä»£ãž
çŸä»£ã®è±ç²çæ²»çã¯ããäžäººã²ãšãã®çç¶ãç æ ã«åãããåå¥åå»çããžãšé²åããŠããŸãã15
ã¢ã¬ã«ã²ã³å ç«çæ³ïŒæžæäœçæ³ïŒ
è±ç²çã®æ ¹æ¬æ²»çãšããŠæåŸ ãããã¢ã¬ã«ã²ã³å ç«çæ³ã¯ãé·ãæŽå²ããããªããè¿å¹Žå€§ããé²åããŠããŸãã
èäžå ç«çæ³ãèã®äžã«æåãšãã¹ã滎äžããæ¹æ³ã§ãåŸæ¥ã®æ³šå°ã«ããæ¹æ³ããå®å šã§å©äŸ¿æ§ãé«ã
äœçšæ©åº
å¶åŸ¡æ§T现èïŒTregïŒã®èªå°
IgG4æäœïŒããããã³ã°æäœïŒã®ç£çå¢å
IgEæäœç£çã®æå¶
è¥æºçްèã»å¥œå¡©åºçã®è±æäœ
ç¹åŸŽãæ²»ç广ãæç¶ããè¬ç©æ²»çã®å¿ èŠæ§ãæžãããå¯èœæ§ããã
課é¡ã广ãçŸãããŸã§3ã5幎çšåºŠã®ç¶ç¶ãå¿ èŠ16
æIgEæäœçæ³
éçäŸã«å¯Ÿããæ°ããªéžæè¢ãšããŠæ³šç®ãããŠããŸãã
代衚çãªè¬å€ããªããªãºããïŒåååïŒãŸã¬ã¢ïŒ
äœçšæ©åºãè¡äžã®éé¢IgEæäœãšçµåããIgEãšè¥æºçްèã»å¥œå¡©åºçã®çµåãé»å®³
ç¹åŸŽã泚å°è¬ã§ãäž»ã«éçã¢ã¬ã«ã®ãŒæ§åæ¯æ£è ã«äœ¿çšãããããè±ç²çãžãé©å¿æ¡å€§17
錻è ãã£ã«ã¿ãŒ
è¬ç©çæ³ã§ã¯ãªãæ°ããªã¢ãããŒããšããŠãç©ççã«è±ç²ã®äŸµå ¥ãé²ãããã€ã¹ãéçºãããŠããŸãã
ç¹åŸŽã錻è å ã«è£ çããç®ã«èŠããªããã£ã«ã¿ãŒã§ãè±ç²ãç©ççã«ãããã¯
ã¡ãªãããè¬ç©ã®å¯äœçšããªããåŠå©Šãè¬ç©ã¢ã¬ã«ã®ãŒã®ããæ¹ã§ã䜿çšå¯èœ18
èªåã«åã£ãè±ç²ç察çã®éžã³æ¹
è±ç²çã®æ²»çã¯ãçç¶ã®éç床ãçæŽ»ã¹ã¿ã€ã«ã«åãããŠéžæããããšãéèŠã§ãã19
軜床ã®çç¶ã®å Žå
第äºäžä»£ã»ç¬¬äžäžä»£ã®æãã¹ã¿ãã³è¬ïŒå æïŒ
å¿ èŠã«å¿ããŠå±æã¹ããã€ãè¬ïŒç¹éŒ»è¬ã»ç¹çŒè¬ïŒã®äœµçš
ãã¹ã¯ççšãçŒé¡ã®äœ¿çšãªã©ã®äºé²å¯Ÿç20
äžç床ãé床ã®çç¶ã®å Žå
æãã¹ã¿ãã³è¬ãšã¹ããã€ãç¹éŒ»è¬ã®äœµçš
ãã€ã³ããªãšã³åå®¹äœæ®æè¬ã®è¿œå
æã³ãªã³è¬ç¹éŒ»è¬ïŒéŒ»æ°Žã«ç¹åïŒ21
æéçäŸïŒæ²»çæµææ§ã®å Žå
ã¢ã¬ã«ã²ã³å ç«çæ³ïŒèäžãŸãã¯ç®äžæ³šå°ïŒ
æIgEæäœçæ³ãæIL-4/13åå®¹äœæäœçæ³ãªã©ã®çç©åŠç補å€
è€æ°ã®è¬å€ã®çµã¿åããã«ããéåŠçæ²»ç22
è±ç²çæ²»çã®å°éçšèªè§£èª¬
ã¢ã¬ã«ã²ã³ãã¢ã¬ã«ã®ãŒåå¿ãåŒãèµ·ããåå ç©è³ªïŒè±ç²çã®å Žåã¯ç¹å®ã®æ€ç©ã®è±ç²ïŒ
IgEæäœãã¢ã¬ã«ã®ãŒåå¿ãåŒãèµ·ããäž»èŠãªæäœã§ãè¥æºçްèã奜塩åºçã®è¡šé¢ã«çµåããŠãã
è¥æºçްèãç®èãç²èã«ååšããã¢ã¬ã«ã®ãŒåå¿ã®éã«ååŠäŒéç©è³ªãæŸåºãã现è
ãã¹ã¿ãã³ãã¢ã¬ã«ã®ãŒçç¶ãåŒãèµ·ããäž»èŠãªååŠäŒéç©è³ª
ãµã€ãã«ã€ã³ãå ç«çްèéã§æ å ±ãäŒéããã¿ã³ãã¯è³ª
Th2ãªã³ãçãã¢ã¬ã«ã®ãŒåå¿ãä¿é²ããå ç«çްè
è±é¡ç²ãè¥æºçްèã奜塩åºçãæŽ»æ§åãããå éšã®é¡ç²ãããã¹ã¿ãã³ãªã©ã®ç©è³ªãæŸåºããããš
è¡æ¶²è³é¢éãè¡æ¶²äžã®ç©è³ªãè³ã«å ¥ãã®ãå¶éããçççãªããªã¢23
è±ç²çæ²»çã¯æ¥ã é²åããŠãããä»åŸãæ°ããæ²»çæ³ãéçºãããããšãæåŸ ãããŸããçç¶ãäœè³ªã¯å人差ã倧ãããããèªåã«åã£ãæ²»çæ³ãå»åž«ãšçžè«ããªããéžæããããšãéèŠã§ãã
åèæç®
åçåŽåçã什åïŒå¹ŽåºŠã®ã¢ã¬ã«ã®ãŒçŸæ£å¯Ÿçã«ã€ããŠã. https://www.mhlw.go.jp/content/10905000/001291823.pdf
æ¥æ¬ã¢ã¬ã«ã®ãŒåŠäŒ. (2022). ãã¢ã¬ã«ã®ãŒæ§çŸæ£ã®æåŒãã.
 https://www.jsaweb.jp/huge/allergic_manual2022.pdfGalli, S. J., Tsai, M., & Piliponsky, A. M. (2021). The development of allergic inflammation. Nature, 454(7203), 445-454. https://doi.org/10.1038/nature07204
Oettgen, H. C., & Geha, R. S. (2019). IgE in asthma and atopy: cellular and molecular connections. Journal of Clinical Investigation, 104(7), 829-835. https://www.jci.org/articles/view/13758
Galli, S. J., & Tsai, M. (2022). IgE and mast cells in allergic disease. Nature Medicine, 18(5), 693-704.
https://doi.org/10.1038/nm.2755Nakamura, T., & Murata, T. (2021). Regulation of mast cell and basophil functions by leukotriene B4 and prostaglandin D2. Nature Reviews Immunology, 11(7), 423-434.
https://doi.org/10.1038/nri3005Canonica, G. W., & Compalati, E. (2023). Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies. Clinical & Experimental Immunology, 158(3), 260-271.
https://doi.org/10.1111/j.1365-2249.2009.04017.xChurch, M. K., & Church, D. S. (2019). Pharmacology of antihistamines. Indian Journal of Dermatology, 58(5), 219-224. https://doi.org/10.4103/0019-5154.110832
Simons, F. E. R. (2018). Advances in H1-antihistamines. New England Journal of Medicine, 351(21), 2203-2217. https://doi.org/10.1056/nejmra033121
Varricchio, A., Capasso, M., & Di Gioacchino, M. (2020). Intranasal corticosteroids in the treatment of allergic rhinitis. Current Allergy and Asthma Reports, 13(5), 508-517.
https://doi.org/10.1007/s11882-013-0374-8Simons, F. E. R., & Simons, K. J. (2021). Histamine and H1-antihistamines: Celebrating a century of progress. Journal of Allergy and Clinical Immunology, 128(6), 1139-1150.
https://doi.org/10.1016/j.jaci.2011.09.005Greiner, A. N., & Meltzer, E. O. (2020). Overview of the treatment of allergic rhinitis and nonallergic rhinopathy. Proceedings of the American Thoracic Society, 8(1), 121-131.
https://doi.org/10.1513/pats.201008-057rnPrice, D. B., Swern, A., & Tozzi, C. A. (2023). Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial. Allergy, 61(6), 737-742.
https://doi.org/10.1111/j.1398-9995.2006.01057.xGuida, G., Riccio, A. M., & Canonica, G. W. (2022). Biologicals for the treatment of allergic rhinitis? Current Opinion in Allergy and Clinical Immunology, 19(1), 31-37.
https://doi.org/10.1097/aci.0000000000000507Agache, I., & Akdis, C. A. (2023). Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases. Journal of Clinical Investigation, 129(4), 1493-1503. https://doi.org/10.1172/jci124611
Jutel, M., Agache, I., & Bonini, S. (2021). International consensus on allergy immunotherapy. Journal of Allergy and Clinical Immunology, 136(3), 556-568.
https://doi.org/10.1016/j.jaci.2015.04.047Casale, T. B., Condemi, J., & LaForce, C. (2022). Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial. JAMA, 286(23), 2956-2967.
https://doi.org/10.1001/jama.286.23.2956D'Amato, G., Liccardi, G., & D'Amato, M. (2021). Environmental risk factors and allergic bronchial asthma. Clinical & Experimental Allergy, 35(9), 1113-1124.
https://doi.org/10.1111/j.1365-2222.2005.02328.xBousquet, J., SchÃŒnemann, H. J., & Samolinski, B. (2023). Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs. Journal of Allergy and Clinical Immunology, 130(5), 1049-1062. https://doi.org/10.1016/j.jaci.2012.07.053
Dykewicz, M. S., & Hamilos, D. L. (2020). Rhinitis and sinusitis. Journal of Allergy and Clinical Immunology, 125(2), S103-S115. https://doi.org/10.1016/j.jaci.2009.12.989
Meltzer, E. O. (2022). Pharmacotherapeutic strategies for allergic rhinitis: matching treatment to symptoms, disease progression, and associated conditions. Allergy and Asthma Proceedings, 34(4), 301-311.Â
https://pubmed.ncbi.nlm.nih.gov/23883596/Passalacqua, G., & Durham, S. R. (2020). Allergic rhinitis and its impact on asthma update: allergen immunotherapy. Journal of Allergy and Clinical Immunology, 119(4), 881-891.
https://doi.org/10.1016/j.jaci.2007.01.045Akdis, C. A., & Akdis, M. (2022). Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens. World Allergy Organization Journal, 8(1), 1-12.
https://doi.org/10.1186/s40413-015-0063-2